Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
Authors:
Open Access
- 27 June 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1367981
Abstract
Cancer stem cells (CSCs) represent a small subset of heterogeneous cells within tumors that possess the ability to self-renew and initiate tumorigenesis. They serve as potential drivers for tumor initiation, metastasis, recurrence, and drug resistance. Recent research has demonstrated that the stemness preservation of CSCs is heavily reliant on their unique lipid metabolism alterations, enabling them to maintain their own environmental homeostasis through various mechanisms. The primary objectives involve augmenting intracellular fatty acid (FA) content to bolster energy supply, promoting β-oxidation of FA to optimize energy utilization, and elevating the mevalonate (MVA) pathway for efficient cholesterol synthesis. Additionally, lipid droplets (LDs) can serve as alternative energy sources in the presence of glycolysis blockade in CSCs, thereby safeguarding FA from peroxidation. Furthermore, the interplay between autophagy and lipid metabolism facilitates rapid adaptation of CSCs to the harsh microenvironment induced by chemotherapy. In this review, we comprehensively review recent studies pertaining to lipid metabolism in CSCs and provide a concise overview of the indispensable role played by LDs, FA, cholesterol metabolism, and autophagy in maintaining the stemness of CSCs.Keywords
This publication has 278 references indexed in Scilit:
- Targeting senescence as an anticancer therapyMolecular Oncology, 2022
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019JAMA Oncology, 2021
- Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolismHepatology, 2017
- Chemical Probes to Directly Profile Palmitoleoylation of ProteinsChemBioChem, 2016
- Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasinCancer Medicine, 2016
- Fatty Acids and Breast Cancer: Make Them on Site or Have Them DeliveredJournal of Cellular Physiology, 2016
- Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1‐ABCG2 signalingMolecular Carcinogenesis, 2015
- The metabolic landscape of cancer stem cellsIUBMB Life, 2015
- Energy Metabolism Characterization of a Novel Cancer Stem Cell‐Like Line 3AB‐OSJournal of Cellular Biochemistry, 2013
- Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic TargetStem Cells, 2012